Sarepta Therapeutics beats by $0.17, misses on revenues

|About: Sarepta Therapeutics, Inc. (SRPT)|By:, SA News Editor

Sarepta Therapeutics (SRPT): Q2 EPS of -$0.46 beats by $0.17.

Revenue of $3.0M misses by $2.08M. (PR)